-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $60

Benzinga·08/05/2026 13:20:49
Listen to the news
Wedbush analyst Robert Driscoll maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Outperform and raises the price target from $58 to $60.